Kiley Juergens Wealth Management LLC Purchases Shares of 2,795 iShares Biotechnology ETF $IBB

Posted by Francis Steltz on Jul 8th, 2026

Kiley Juergens Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 2,795 shares of the financial services provider’s stock, valued at approximately $472,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Whittier Trust Co. of Nevada Inc. lifted its position in iShares Biotechnology ETF by 54.9% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 2,992 shares of the financial services provider’s stock worth $505,000 after buying an additional 1,060 shares during the last quarter. Stephens Inc. AR grew its position in iShares Biotechnology ETF by 2.1% during the first quarter. Stephens Inc. AR now owns 7,454 shares of the financial services provider’s stock valued at $1,259,000 after acquiring an additional 154 shares during the last quarter. Bravias Capital Group LLC raised its stake in shares of iShares Biotechnology ETF by 9.6% during the first quarter. Bravias Capital Group LLC now owns 2,348 shares of the financial services provider’s stock worth $396,000 after acquiring an additional 206 shares in the last quarter. Howe & Rusling Inc. raised its stake in shares of iShares Biotechnology ETF by 80.2% during the first quarter. Howe & Rusling Inc. now owns 1,013 shares of the financial services provider’s stock worth $171,000 after acquiring an additional 451 shares in the last quarter. Finally, QRG Capital Management Inc. bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth approximately $222,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.5%

Shares of iShares Biotechnology ETF stock opened at $198.23 on Wednesday. iShares Biotechnology ETF has a 52-week low of $128.06 and a 52-week high of $198.71. The company has a fifty day moving average of $174.23 and a 200-day moving average of $172.27.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.